diethylcarbamazine has been researched along with Melanoma in 1 studies
Diethylcarbamazine: An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cultured human melanoma M21 cells were treated with diethylcarbamazine (DEC), an inhibitor of proteoglycan biosynthesis in rat chondrosarcoma cells, to examine the assembly and transport of a chondroitin sulfate proteoglycan to the plasma membrane." | 7.67 | Inhibition of post-translational modification and surface expression of a melanoma-associated chondroitin sulfate proteoglycan by diethylcarbamazine or ammonium chloride. ( Austen, KF; Caulfield, JP; Harper, JR; Hein, A; Parsons, WG; Perry, SK; Reisfeld, RA; Spiro, RC; Stevens, RL, 1986) |
| "Cultured human melanoma M21 cells were treated with diethylcarbamazine (DEC), an inhibitor of proteoglycan biosynthesis in rat chondrosarcoma cells, to examine the assembly and transport of a chondroitin sulfate proteoglycan to the plasma membrane." | 3.67 | Inhibition of post-translational modification and surface expression of a melanoma-associated chondroitin sulfate proteoglycan by diethylcarbamazine or ammonium chloride. ( Austen, KF; Caulfield, JP; Harper, JR; Hein, A; Parsons, WG; Perry, SK; Reisfeld, RA; Spiro, RC; Stevens, RL, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spiro, RC | 1 |
| Parsons, WG | 1 |
| Perry, SK | 1 |
| Caulfield, JP | 1 |
| Hein, A | 1 |
| Reisfeld, RA | 1 |
| Harper, JR | 1 |
| Austen, KF | 1 |
| Stevens, RL | 1 |
1 other study available for diethylcarbamazine and Melanoma
| Article | Year |
|---|---|
Inhibition of post-translational modification and surface expression of a melanoma-associated chondroitin sulfate proteoglycan by diethylcarbamazine or ammonium chloride.
Topics: Ammonium Chloride; Cell Line; Chondroitin Sulfate Proteoglycans; Diethylcarbamazine; Disaccharides; | 1986 |